Advanced Medical Imaging Development (AMID), one of the main Italian MedTech companies active in the analysis and advanced quantification of cardiac and cardiovascular imaging, was purchased by the Dutch Medis Medical Imaging Systems, a company participated since May 2018 by Van Herk Ventures. The latter is the investment vehicle of the financier Van Herk, focused on the life science sector, with a long-term horizon, through direct investments in private and listed companies and venture capital funds.
The financial boutique BF & Company advised the sellers. DWF (Italy) also acted in the operation for legal assistance and the preparation of contracts, and Studio Leombruni e Associati for tax and accounting matters.
AMID, founded in 2000 by Giovanni Tonti and Gianni Pedrizzetti, offers solutions for the diagnosis and treatment of cardiovascular diseases. After about 20 years of activity, the AMID partners have completed a succession path through this operation, guaranteeing a new phase of expansion for AMID with the union of forces with an important Dutch player who will provide their skills, resources and their commercial network. In addition, AMID members will have a key role in the transition phase to ensure an effective and regular handover.
Medis, founded in 1989 as a spin-off of the Leiden University Medical Center, is one of the main MedTech companies focused on the development, validation, international marketing and support of multi-vendor analytical software solutions in the cardiovascular field, including X-rays, IVUS, OCT, MRI and MSCT applications. Medis has a global presence thanks to a subsidiary in the United States and offices in Japan and the United Kingdom.
Giovanni Tonti and Gianni Pedrizzetti commented: “We are happy to have identified the ideal partner in Medis, thanks to their technical skills and the global commercial network, capable of supporting the development of AMID and guaranteeing the best service for our customers. We thank the team of BF & Company who managed a well-structured cross-border M&A process in the midst of the COVID-19 pandemic, showing a great understanding of the business, negotiating rigor and access to numerous blue chip investors, thus achieving a market assessment fully informed by AMID, well beyond our expectations “.
Alessandro Bartolini, managing partner of BF & Company, commented: “Thanks to the strong sectorial expertise and the international network of our team, we are proud to announce the second transaction successfully concluded by BF & Company in the healthcare sector within 6 months , after we had already organized our first club deal at the end of 2019 with the Genoese company Gardening, a leader in the disposable medical gloves sector (see here a previous article by BeBeez). The goal is always to be able to collaborate with companies characterized by strong know-how and with successful products and solutions, in order to accelerate their expansion “.
Some members of the BF & Company team participated as promoters-investors in the Gardening club deal. Founded in Milan in 2017 by Alessandro Bartolini (ex Creditanstalt-Bank Austria, UniCredit, PwC, Finanziaria Internazionale), BF & Company until then had been active only in extraordinary financial transactions with a role of financial advisor, which as it continues to to carry out, but to which he has now also joined the club deal arranger in Italian SMEs.
